Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 14, 2009, Pages 6123-6128

  Kuhad, Anurag ^a   Sachdeva, Anand Kamal ^a   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Apoptosis; Caspase 3; Diabetic nephropathy; Nfkk oxidative nitrosative stress; Sesamol; Tgf 1 tnf

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; INSULIN; NITRIC OXIDE; PHENOL DERIVATIVE; SESAMOL;

ANIMAL; APOPTOSIS; ARTICLE; DIABETIC NEPHROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; KIDNEY; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS; BENZODIOXOLES; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; INSULIN; KIDNEY; LIPID PEROXIDATION; MALE; NITRIC OXIDE; OXIDATIVE STRESS; PHENOLS; RATS; RATS, WISTAR;

RATTUS;

EID: 67650896212     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf901388g     Document Type: Article

References (34)

1. Navarro-Gonzalez, J. F.; Mora-Fernandez, C. The role of inflammatory cytokines in diabetic nephropathy. J. Am. Soc. Nephrol. 2008, 19, 433-442.
2. Williams, M. D.; Nadler, J. L. Inflammatory mechanisms of diabetic complications. Curr. Diabetes Rep. 2007, 7, 242-248.
3. Navarro, J. F.; Mora, C. Role of inflammation in diabetic complications. Nephrol. Dial. Trans. 2005, 20, 2601-2604.
4. Mora, C.; Navarro, J. F. Inflammation and diabetic nephropathy. Curr. Diabetes Rep. 2006, 6, 463-468.
5. Komers, R.; Schutzer, W.; Xue, H.; Oyama, T. T.; Lindsley, J. N.; Anderson, S. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats. Translational Res. 2007, 150, 343-349.
6. Levine, D. Z. Hyperfiltration, nitric oxide, and diabetic nephropathy. Curr. Hypertension Rep. 2006, 5, 153-157.
7. Pantsulaia, T. Role of TGF-beta in pathogenesis of diabetic nephropathy. Georgian Med. News 2006, 131, 13-18.
8. Mezzano, S.; Droguett, A.; Burgos, M. E.; Ardiles, L.; Flores, C.; Schneider, H.; Ruiz-Ortega, M.; Egido, J. NF-kappa B activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol. Dial. Transplant 2004, 19, 2505-2512.
9. Schmid, H.; Boucherot, A.; Yasuda, Y.; Henger, A.; Brunner, B.; Eichinger, F.; Nitsche, A.; Kiss, E.; Bleich, M.; Grone, H. J.; Nelson, P. J.; Schlondorff, D.; Cohen, C. D.; Kretzler, M. for European Renal cDNA Bank (ERCB) Consortium. Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 2006, 55, 2993-3003.
10. Parihar, V. K.; Prabhakar, K. R.; Veerapur, V. P.; Kumar, M. S.; Reddy, Y. R.; Joshi, R.; Unnikrishnan, M. K.; Rao, C. M. Effect of sesamol on radiation-induced cytotoxicity in Swiss albino mice. Mutat. Res. 2006, 611, 9-16.
11. Prasada, N. R.; Mahesha, T.; Menona, V. P.; Jeevanramb, R. K.; Pugalendia, K. V. Photoprotective effect of sesamol on UVBradiation induced oxidative stress in human blood lymphocytes in vitro. Environ. Toxicol. Pharmacol. 2005, 20, 1-5.
12. Uchida, M.; Nakajn, S.; Toyoshima, M. Antioxidative effect of sesamol and related compounds on lipid peroxidation. Biol. Pharm. Bull. 1916, 19, 623-626.
13. Joshi, R.; Kumar, M. S.; Satyamoorthy, K.; Unnikrisnan, M. K.; Mukherjee, T. Free radical reactions and antioxidant activities of sesamol: pulse radiolytic and biochemical studies. J. Agrie. Food Chem. 2005, 53, 2696-2703.
14. Prasada, N. R.; Menona, V. P.; Vasud3evb, V; Pugalendia, K. V. Radioprotective effect of sesamol on radiation induced DNA damage, lipid peroxidation and antioxidants levels in cultured human lymphocytes. Toxicology 2005, 209, 225-235.
15. Kapadia, J. G.; Azuine, M.; Tokuda, H.; Takasaki, M.; Mukainaka, T.; Konoshima, T.; Nishino, H. Chemopreventive effect of resveratrol, sesamol, sesame oil and sunflower oil in the Epstein-Barr virus early antigen activation assay and the mouse skin two-stage carcinogenesis. Pharmacol. Res. 2002, 45, 499-505.
16. Hou, R. C.; Chen, Y. S.; Chen, C. H.; Chen, Y. H.; Jeng, K. C. Protective effect of 1,2,4-benzenetriol on LPS-induced NO production by BV2 microglial cells. J. Biomed. Sci. 2006, 13, 89-99.
17. Hsu, D. Z.; Chen, K. T.; Li, Y. H.; Chuang, Y. C.; Liu, M. Y. Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: role of oxidative stress. Shock 2006, 25, 528-532.
18. Sharma, S.; Kaur, I. P. Development and evaluation of sesamol as an antiaging agent. Int. J. Dermatol. 2006, 45, 200-208.
19. Kuhad, A.; Chopra, K. Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. Eur. J. Pharmacol. 2007, 576, 34-42.
20. Kuhad, A.; Sharma, S.; Chopra, K. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur. J. Pain 2008, 12, 624-632.
21. Kuhad, A.; Chopra, K. Effect of sesamol on diabetes-associated cognitive decline in rats. Exp. Brain Res. 2008, 185, 411-420.
22. Konrad, R. J.; Mikolaenko, I.; Tolar, J. F.; Liu, K.; Kudlow, J. E. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetylβ-D-glucosaminidase. Biochem. J. 2001, 356, 31-41.
23. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95, 351-358.
24. Jollow, D. J.; Mitchell, J. R.; Zampaglione, N.; Gillette, J. R. Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzenoxide as the hepatotoxic intermediate. Pharmacology 1974, 11, 151-169.
25. Kono, Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 1978, 186, 189-195.
26. Claiborne, A. In Handbook of Methods for Oxygen Radical Research; Greenwald, R. A., Ed.; CRC Press: Boca Raton, FL, 1985; pp 283 - 284.
27. Sharma, S.; Anjaneyulu, M.; Kulkami, S. K.; Chopra, K. Resveratrol, a polyphenols phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 2006, 76, 69-75.
28. Sharma, S.; Kulkami, S. K.; Chopra, K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 2006, 33, 940945.
29. Hsu, D. Z.; Chien, S. P.; Chen, K. T.; Liu, M. Y. The effect of sesamol on systemic oxidative stress and hepatic dysfunction in acutely iron-intoxicated mice. Shock 2007, 28, 596-601.
30. Petersen, M.; Thorikay, M.; Deckers, M.; van Dinther, M.; Grygielko, E. T.; Gellibert, F.; de Gouville, A. C.; Huet, S.; ten Dijke, P.; Laping, N. J. Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis. Kidney Int. 2008, 73, 705-715.
31. Navarro, J.; Milena, F.; Mora, C.; Leon, C.; Claverie, F.; Flores, C.; Garcia, J. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin converting enzyme inhibition. Kidney Int. 2005, 99, S98-S102.
32. DiPetrillo, K.; Gesek, F. A. Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats. Am. J. Nephrol. 2004, 24, 352-359.
33. Yamamoto, Y.; Gaynor, R. B. Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 2001, 1, 287-296.
34. Allen, D. A.; Harwood, S.; Varagunam, M.; Raftery, M. J.; Yaqoob, M. M. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J. 2003, 17, 908-910.